Target

TGT

Market cap $41B

Target, Baidu, and Disney are three of my favorite stocks to buy right now. I have added to my Target and Baidu positions recently, and I've owned Disney for almost 40 years.

Costco has been performing well as a business despite its recent price drawdown. Target has been performing poorly as a business, and the stock has fallen into its own bear market.

Target Corporation (TGT) faces ongoing operational challenges, weak free cash flow, and a high debt load, putting its 57-year dividend streak at risk. TGT's core discretionary categories are in decline, with growth limited to lower-margin food and essentials, reflecting cautious consumer behavior and structural margin pressure. Rising Capex commitments and a dividend funding gap threaten the sustainability of TGT's payout, with management signaling no near-term turnaround in business dynamics.

Target continues to generate sufficient cash to cover its growing dividend. Chevron can support its dividend at lower oil prices while maintaining upside potential if oil prices recover.

Target's app in ChatGPT, AI-powered Gift Finder and Deals page make it easier than ever to discover and buy Cyber deals Target's Cyber Monday sale from Nov. 30 – Dec. 1 offers savings of up to 50% off thousands of trending items across top national brands, guest-favorite owned brands and an expanded Target Plus marketplace MINNEAPOLIS , Nov. 28, 2025 /PRNewswire/ -- This Cyber Monday, Target (NYSE: TGT) is reimagining holiday shopping. From the moment they open the Target app or visit Target.com, guests will experience a new kind of Cyber Monday — one powered by AI, personalization and ease, designed to make finding the perfect gift joyful, not stressful.

CNBC's "The Exchange" team discusses how AI may transform shopping amid the holiday season with Shikha Jain, lead partner for consumer and retail at Simon-Kucher.

Thanksgiving is upon us , followed by the busiest in-store shopping day of the year: Black Friday.

Target's extensive footprint helps make it a leader in omnichannel retailing. The declining stock price and annual dividend increases have led to generous payouts.

TORONTO--(BUSINESS WIRE)-- #ARDS--Vasomune Therapeutics and AnGes Commit to Development of Additional Indications for Pegevongitide (AV-001).

Target announced a $5 billion investment to expand with larger stores and revamp existing locations despite ongoing sales challenges and market pressures.